DE60321774D1 - Aerosol-formulierungen von formoterol und mometason - Google Patents
Aerosol-formulierungen von formoterol und mometasonInfo
- Publication number
- DE60321774D1 DE60321774D1 DE60321774T DE60321774T DE60321774D1 DE 60321774 D1 DE60321774 D1 DE 60321774D1 DE 60321774 T DE60321774 T DE 60321774T DE 60321774 T DE60321774 T DE 60321774T DE 60321774 D1 DE60321774 D1 DE 60321774D1
- Authority
- DE
- Germany
- Prior art keywords
- formoterol
- mometason
- aerosol formulations
- solvate
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/14—Disinfection, sterilisation or deodorisation of air using sprayed or atomised substances including air-liquid contact processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0207906.9A GB0207906D0 (en) | 2002-04-05 | 2002-04-05 | Formoterol and mometasone aerosol formulations |
| PCT/US2003/008710 WO2003086350A1 (en) | 2002-04-05 | 2003-03-21 | Formoterol and mometasone aerosol formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60321774D1 true DE60321774D1 (de) | 2008-08-07 |
Family
ID=9934328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60321774T Expired - Lifetime DE60321774D1 (de) | 2002-04-05 | 2003-03-21 | Aerosol-formulierungen von formoterol und mometason |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8252268B2 (de) |
| EP (1) | EP1492499B1 (de) |
| AT (1) | ATE398999T1 (de) |
| AU (1) | AU2003225915A1 (de) |
| DE (1) | DE60321774D1 (de) |
| GB (1) | GB0207906D0 (de) |
| WO (1) | WO2003086350A1 (de) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004020289A1 (en) * | 2002-08-27 | 2004-03-11 | Schering Corporation | Process for producing metered dose inhaler formulations |
| SE0301260D0 (sv) * | 2003-04-29 | 2003-04-29 | Astrazeneca Ab | Novel equipment |
| ES2544477T3 (es) | 2003-10-03 | 2015-08-31 | 3M Innovative Properties Company | Imidazoquinolinas sustituidas con alcoxi |
| MXPA06005910A (es) | 2003-11-25 | 2006-08-23 | 3M Innovative Properties Co | Sistemas de anillo imidazo sustituido y metodos. |
| JP2008530022A (ja) | 2005-02-04 | 2008-08-07 | コーリー ファーマシューティカル グループ，インコーポレイテッド | 免疫反応調節物質を含む水性ゲル処方物 |
| JP5107933B2 (ja) * | 2005-12-21 | 2012-12-26 | メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | 炎症性疾患の治療に使用する、抗コリン作用薬類、β２−アドレナリン受容体のアゴニスト類、抗ロイコトリエン（ロイコトリエン受容体のアンタゴニスト）類、グルココルチコイド類および／またはＰＤＥ４阻害剤類の新規配合薬 |
| EP1894568A1 (de) * | 2006-08-31 | 2008-03-05 | Novartis AG | Pharmazeutische Zusammensetzungen zur Behandlung von entzündlichen oder obstruktiven Atemwegserkrankungen |
| WO2008097233A1 (en) * | 2007-02-09 | 2008-08-14 | Schering Corporation | Stable pharmaceutical drug aerosols |
| CN108434126B (zh) | 2009-03-26 | 2021-11-19 | 普马特里克斯营业公司 | 治疗肺病的干粉配方与方法 |
| CA2754684A1 (en) * | 2009-03-26 | 2010-09-30 | Pulmatrix, Inc. | Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining |
| PL2435024T3 (pl) * | 2009-05-29 | 2017-01-31 | Pearl Therapeutics, Inc. | Dostarczanie substancji czynnych do dróg oddechowych oraz powiązane sposoby i systemy |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| WO2011015226A1 (en) * | 2009-08-03 | 2011-02-10 | Pharmatex Italia Srl | Process for the preparation of sterile powdered pharmaceutical compounds in the form of micro and nanoparticles |
| EP2533765A2 (de) * | 2010-01-29 | 2012-12-19 | Mahmut Bilgic | Pharmazeutische zusammensetzungen mit formoterol und mometason |
| WO2012030645A1 (en) | 2010-08-30 | 2012-03-08 | Pulmatrix, Inc. | Respirably dry powder comprising calcium lactate, sodium chloride and leucine |
| AU2011296343B2 (en) | 2010-08-30 | 2015-12-10 | Pulmatrix Operating Company, Inc. | Dry powder formulations and methods for treating pulmonary diseases |
| ES2710537T3 (es) | 2010-09-29 | 2019-04-25 | Pulmatrix Operating Co Inc | Polvos secos catiónicos |
| IL286573B (en) | 2010-09-29 | 2022-08-01 | Pulmatrix Operating Co Inc | Monovalent metal cation dry powders for inhalation |
| NZ629722A (en) | 2012-02-29 | 2017-03-31 | Pulmatrix Operating Co Inc | Inhalable dry powders |
| CA2905542C (en) | 2013-03-15 | 2022-05-03 | Pearl Therapeutics, Inc. | Methods and systems for conditioning of particulate crystalline materials |
| CA2907566C (en) | 2013-04-01 | 2023-08-22 | Pulmatrix, Inc. | Tiotropium dry powders |
| WO2015199626A1 (en) * | 2014-06-27 | 2015-12-30 | World Medicine İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | STABLE AEROSOL FORMULATIONS OF β2- ADRENERGIC AGONISTS |
| EP3174522A1 (de) | 2014-07-29 | 2017-06-07 | 3M Innovative Properties Company | Verfahren zur herstellung einer pharmazeutischen zusammensetzung |
| EP3383366B2 (de) | 2015-12-04 | 2024-06-05 | Mexichem Fluor S.A. de C.V. | Pharmazeutische zusammensetzung |
| GB2545025A (en) * | 2015-12-04 | 2017-06-07 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
| US20240189244A1 (en) * | 2021-04-09 | 2024-06-13 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for delivering pharmaceutical agents |
| US11964121B2 (en) | 2021-10-13 | 2024-04-23 | Satio, Inc. | Mono dose dermal patch for pharmaceutical delivery |
| US12048543B2 (en) | 2021-11-08 | 2024-07-30 | Satio, Inc. | Dermal patch for collecting a physiological sample with removable vial |
| US12178979B2 (en) | 2021-10-13 | 2024-12-31 | Satio, Inc. | Dermal patch for delivering a pharmaceutical |
| US12023156B2 (en) | 2021-10-13 | 2024-07-02 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US12214346B2 (en) | 2021-10-13 | 2025-02-04 | Satio, Inc. | Dermal patch with a diagnostic test strip |
| US11877848B2 (en) | 2021-11-08 | 2024-01-23 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US11452474B1 (en) | 2021-04-14 | 2022-09-27 | Satio, Inc. | Dual lever dermal patch system |
| US12053284B2 (en) | 2021-11-08 | 2024-08-06 | Satio, Inc. | Dermal patch for collecting a physiological sample |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE8790T1 (de) | 1981-02-02 | 1984-08-15 | Schering Corporation | Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. |
| DE69104991T2 (de) * | 1990-09-10 | 1995-04-20 | Schering Corp | Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen. |
| US5795564A (en) | 1991-04-05 | 1998-08-18 | Sepracor, Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
| EP0689424B1 (de) | 1993-03-17 | 1998-10-14 | Minnesota Mining And Manufacturing Company | Aerosolzusammensetzung enthaltend einen aus ester-, amid- oder merkaptoester- derivat dispergiermittel |
| JPH08507792A (ja) | 1993-03-17 | 1996-08-20 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | ジオール−二酸から誘導される分散助剤を含むエーロゾル配合物 |
| PE44995A1 (es) | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
| CA2217950C (en) * | 1995-04-14 | 2001-12-25 | Glaxo Wellcome Inc. | Metered dose inhaler for albuterol |
| GB9612297D0 (en) * | 1996-06-11 | 1996-08-14 | Minnesota Mining & Mfg | Medicinal aerosol formulations |
| TW475901B (en) | 1996-08-29 | 2002-02-11 | Schering Corp | Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| CA2271004C (en) | 1996-11-11 | 2007-05-01 | Sepracor Inc. | Process for the preparation of optically pure isomers of formoterol |
| US6129905A (en) | 1997-04-21 | 2000-10-10 | Aeropharm Technology, Inc. | Aerosol formulations containing a sugar as a dispersant |
| US6264923B1 (en) | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
| DK1102579T3 (da) | 1998-08-04 | 2003-07-14 | Jago Res Ag | Medicinske aerosolformuleringer |
| GB9904919D0 (en) | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
| SE9900833D0 (sv) * | 1999-03-09 | 1999-03-09 | Astra Ab | Novel combination |
| GB0009609D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Therapeutic compositions |
| GB0009612D0 (en) | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Therapeutic formulations |
| US20020076382A1 (en) | 2000-08-04 | 2002-06-20 | Kaplan Leonard W. | Formulations of mometasone and a bronchodilator for pulmonary administration |
| CZ2003983A3 (cs) * | 2000-10-09 | 2003-09-17 | 3M Innovative Properties Company | Léčivé aerosolové přípravky |
| US20040081627A1 (en) * | 2000-10-09 | 2004-04-29 | Jinks Phillip A | Medicinal aerosol formulations |
| AR036358A1 (es) * | 2001-08-28 | 2004-09-01 | Schering Corp | Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma |
| WO2004020289A1 (en) | 2002-08-27 | 2004-03-11 | Schering Corporation | Process for producing metered dose inhaler formulations |
-
2002
- 2002-04-05 GB GBGB0207906.9A patent/GB0207906D0/en not_active Ceased
-
2003
- 2003-03-21 DE DE60321774T patent/DE60321774D1/de not_active Expired - Lifetime
- 2003-03-21 US US10/509,184 patent/US8252268B2/en not_active Expired - Lifetime
- 2003-03-21 EP EP03746547A patent/EP1492499B1/de not_active Expired - Lifetime
- 2003-03-21 AU AU2003225915A patent/AU2003225915A1/en not_active Abandoned
- 2003-03-21 WO PCT/US2003/008710 patent/WO2003086350A1/en not_active Ceased
- 2003-03-21 AT AT03746547T patent/ATE398999T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE398999T1 (de) | 2008-07-15 |
| GB0207906D0 (en) | 2002-05-15 |
| AU2003225915A1 (en) | 2003-10-27 |
| US8252268B2 (en) | 2012-08-28 |
| EP1492499A1 (de) | 2005-01-05 |
| EP1492499B1 (de) | 2008-06-25 |
| US20050255049A1 (en) | 2005-11-17 |
| WO2003086350A1 (en) | 2003-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60321774D1 (de) | Aerosol-formulierungen von formoterol und mometason | |
| CY1109212T1 (el) | Φαρμακευτικες συνθεσεις για την θεραπεια του ασθμα | |
| CA2362499A1 (en) | Combinations of formoterol and mometasone furoate for asthma | |
| CA2381329A1 (en) | Medicaments | |
| DK0553298T3 (da) | Aerosolformulering omfattende beclomethason-17,21-dipropionat | |
| YU59899A (sh) | Medicinski aerosolni proizvodi | |
| AR013506A1 (es) | Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida | |
| DE69231994D1 (de) | Fluorchlorkohlenwasserstofffreie Aerosolformulierungen | |
| PT731688E (pt) | Formulacoes de farmacos em aerossol para utilizacao com propulsores sem cfc | |
| BG102689A (bg) | Фармацевтичен аерозолен състав за използване при лечение на респираторни смущения | |
| MY126768A (en) | Combinations of formoterol and fluticasone propionate for asthma | |
| DE60114571D1 (de) | Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung | |
| DE122011100060I1 (de) | Cannabis enthaltende pharmazeutische zusammensetzungen. | |
| HUP0000587A1 (hu) | Takrolimuszt (FK506) tartalmazó gyógyszerkészítmény | |
| DE60019167D1 (de) | Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason | |
| NO20083759L (no) | Doserings aerosoler for administrering av farmasoytiske preparater | |
| WO2005044186A3 (en) | Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same | |
| NO980858D0 (no) | Farmasöytiske preparater og anordninger for administrering derav | |
| BG107257A (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
| EP2612703A3 (de) | Partikelmaterialien | |
| DE60311665D1 (de) | Pharmazeutische zusammensetzungen | |
| EP1031352A3 (de) | Verwendung von Desmopressin zur Zubereitung eines Arzneimittels gegen metastatische Verbreitung während einer Krebschirurgie | |
| WO2005011595A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease | |
| WO2005011615A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease | |
| WO2004103339A3 (en) | Improved metered dose inhaler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |